scholarly journals DEVELOPMENT OF THE QUESTIONNAIRE ON COMPLIANCE TO MEDICAL NUTRITION THERAPY FOR TYPE 2 DIABETIC PATIENTS AND ASSESSMENT OF ITS POTENTIAL USE

2016 ◽  
Vol 44 (4) ◽  
pp. 422-429 ◽  
Author(s):  
E. G. Starostina ◽  
E. P. Shavrikova
2018 ◽  
Vol 46 (3) ◽  
pp. 240-253
Author(s):  
E. G. Starostina

Background:The actual structure of nutrition and associated factors in the Russian type 2 diabetic patients have not been systematically evaluated.Aim:To assess type 2 patients' perceptions of the diet recommendations given by their doctors, how do they deflect in the actual nutrition structure depending on demographic, medical and social factors.Materials and methods: 297  out- and in-patients with type 2 diabetes mellitus were consecutively recruited into this cross-sectional study (mean age ± standart deviation, 61.0 ± 10.1 years, with duration of diabetes from 1 to 35  years). 21% of the patients were treated with the diet only, 53%, with oral hypoglycemic agents (OHA), 26%, with insulin or insulin + OHA. In addition to their comprehensive clinical and laboratory assessment, the patients filled in the following questionnaires: 1) to assess their obstacles and barriers with diabetes treatment; 2) to assess the diet recommendations and factors that might influence their choice of foods; 3) to assess the nutritional structure. The data is given as mean ± standard deviation.Results:Diet was chosen as the most challenging aspect of diabetes treatment by 53% of patients, whereas insulin therapy was found to be most challenging by 12% of them, blood glucose self-monitoring by 10% and OHA treatment by 4%. The patient's diet is influenced most of all by recommendations given by their doctors (66%), with tastes and nutritional habits of the patients ranking second (48%), their well-being ranking 3rd(43%), and food costs ranking 4th (40%) with a small difference with the 3rd. The analysis of patients' understanding of the diet components and evaluation of their actual nutritional structure showed their non-concordance with current evidenced-based approaches to medical nutrition. The patient's nutrition is dominated by exclusion of fast-absorbable carbohydrates and total carbohydrate restriction, as well as by an excessive intake of vegetable oils and unfounded restraint from fried and spicy foods. Total daily caloric intake was reduced only by 37% of the patients. The patients undervalue the necessity of increased fiber intake. The group of very highly consumed foods (≥ 75% of the patients) included vegetable oils (84.0%), soft drinks (82.9%) and dairy products (78.9%). The group of highly consumed foods (50–74% of the patients) included soups (72.6%), meat, fish and poultry (70.5%), grains and cereals (total, 69.9%), vegetables, greenery and beans (68.9%), potatoes (58.9%), and fruits and berries (52.2%). The group of moderately consumed foods (25–49% of the patients) included bread and bakery products (44.5%) and eggs (27.9%), whereas the least consumed (< 25% of the patients) were “diabetic foods” (19.4%), pasta (17.1%), fat sauces and cream (21.4%), butter and lard (15.7%), nuts (14.5%), oils preserves and smoked foods (5.7%), and sweets (4.7%). The most unhealthy diet was typical for male patients, those of relatively young age, with short diabetes duration, with obesity and with lower educational level.Conclusion:Diet is seen by type 2 diabetic patients as the most burdening treatment element. Nutritional structure of type 2 diabetic patients, including those who have participated in the patient education programs, in many ways is not consistent with the current principles of rational medical nutrition and is determined first of all by recommendations of their doctors that are not always optimal. The use of the questionnaire to assess nutritional structure and regularity allows to evaluate the diet style of a given patient and, based on it, to elaborate corrective measures and individual dietetic recommendations.


Author(s):  
Giuseppe Derosa ◽  
Angela D’Angelo ◽  
Chiara Martinotti ◽  
Maria Chiara Valentino ◽  
Sergio Di Matteo ◽  
...  

Abstract. Background: to evaluate the effects of Vitamin D3 on glyco-metabolic control in type 2 diabetic patients with Vitamin D deficiency. Methods: one hundred and seventeen patients were randomized to placebo and 122 patients to Vitamin D3. We evaluated anthropometric parameters, glyco-metabolic control, and parathormone (PTH) value at baseline, after 3, and 6 months. Results: a significant reduction of fasting, and post-prandial glucose was recorded in Vitamin D3 group after 6 months. A significant HbA1c decrease was observed in Vitamin D3 (from 7.6% or 60 mmol/mol to 7.1% or 54 mmol) at 6 months compared to baseline, and to placebo (p < 0.05 for both). At the end of the study period, we noticed a change in the amount in doses of oral or subcutaneous hypoglycemic agents and insulin, respectively. The use of metformin, acarbose, and pioglitazone was significantly lower (p = 0.037, p = 0.048, and p = 0.042, respectively) than at the beginning of the study in the Vitamin D3 therapy group. The units of Lispro, Aspart, and Glargine insulin were lower in the Vitamin D3 group at the end of the study (p = 0.031, p = 0.037, and p = 0.035, respectively) than in the placebo group. Conclusions: in type 2 diabetic patients with Vitamin D deficiency, the restoration of value in the Vitamin D standard has led not only to an improvement in the glyco-metabolic compensation, but also to a reduced posology of some oral hypoglycemic agents and some types of insulin used.


VASA ◽  
2005 ◽  
Vol 34 (2) ◽  
pp. 113-117 ◽  
Author(s):  
Papanas ◽  
Symeonidis ◽  
Maltezos ◽  
Giannakis ◽  
Mavridis ◽  
...  

Background: The purpose of this study is to evaluate the severity of aortic arch calcification among type 2 diabetic patients in association with diabetes duration, diabetic complications, coronary artery disease and presence of cardiovascular risk factors. Patients and methods: This study included 207 type 2 diabetic patients (101 men) with a mean age of 61.5 ± 8.1 years and a mean diabetes duration of 13.9 ± 6.4 years. Aortic arch calcification was assessed by means of posteroanterior chest X-rays. Severity of calcification was graded as follows: grade 0 (no visible calcification), grade 1 (small spots of calcification or single thin calcification of the aortic knob), grade 2 (one or more areas of thick calcification), grade 3 (circular calcification of the aortic knob). Results: Severity of calcification was grade 0 in 84 patients (40.58%), grade 1 in 64 patients (30.92%), grade 2 in 43 patients (20.77%) and grade 3 in 16 patients (7.73%). In simple regression analysis severity of aortic arch calcification was associated with age (p = 0.032), duration of diabetes (p = 0.026), insulin dependence (p = 0.042) and presence of coronary artery disease (p = 0.039), hypertension (p = 0.019), dyslipidaemia (p = 0.029), retinopathy (p = 0.012) and microalbuminuria (p = 0.01). In multiple regression analysis severity of aortic arch calcification was associated with age (p = 0.04), duration of diabetes (p = 0.032) and presence of hypertension (p = 0.024), dyslipidaemia (p = 0.031) and coronary artery disease (p = 0.04), while the association with retinopathy, microalbuminuria and insulin dependence was no longer significant. Conclusions: Severity of aortic arch calcification is associated with age, diabetes duration, diabetic complications (retinopathy, microalbuminuria), coronary artery disease, insulin dependence, and presence of hypertension and dyslipidaemia.


1992 ◽  
Vol 68 (03) ◽  
pp. 253-256 ◽  
Author(s):  
Thomas Vukovich ◽  
Sylvia Proidl ◽  
Paul Knöbl ◽  
Harald Teufelsbauer ◽  
Christoph Schnack ◽  
...  

SummaryBeside hypercoagulation and hyperactivated platelets disturbances of the fibrinolytic system towards hypofibrinolysis have been reported to be associated with both glycemic and lipidemic derangement in diabetic patients. In the present prospective follow-up study the effect of 16 weeks insulin treatment and glycemic regulation on plasma levels of tissue plasminogen activator (tPA) and plasminogen activator inhibitor-1 (PAI-1), the main regulators of fibrinolysis, was investigated in 19 type-2 diabetic patients with secondary failure to sulphonylureas. A similar glycemic regulation was obtained in a control group of 10 type 2 diabetic patients with sufficient metabolic response to strict dietary treatment and continuation of sulphonylurea treatment. Compared to 27 healthy subjects levels of tPA and PAI-1 were not significantly increased in type 2 diabetic patients before metabolic intervention. Although a hypofibrinolytic state due to an increase of PAI-1 levels was previously reported in obese hyperinsulinemic patients, no effect of insulin treatment on both tPA- and PAI-1 levels was observed in the present study including patients with only slightly increased body mass index (median 26.0 kg/m2). By correlation analysis PAI-1 levels were significantly related to serum cholesterol (R = 0.52) and glycemic control (glucose R = 0.41) in the whole group of diabetic patients at entry and in both subgroups after 16 weeks of treatment (insulin group: cholesterol R = 0.46, HbA1c R = 0.51; sulphonylurea group: cholesterol R = 0.59, HbA1c R = 0.58). In healthy subjects tPA and PAI-1 was correlated to serum insulin (R = 0.54, R = 0.56) and triglycerides (R = 0.46, R = 0.40). In conclusion, our results indicate that insulin treatment associated with metabolic improvement has no adverse effect to fibrinolysis in type 2 diabetic patients.


Sign in / Sign up

Export Citation Format

Share Document